Hikaru Sakamoto
Nagasaki, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Comparison of clinical characteristics and cytogenetic abnormalities between myelodysplastic syndromes in Nagasaki atomic bomb survivors and therapy-related myelodysplastic syndromes
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: August 30, 2026
Multifocal motor neuropathy following allogeneic hematopoietic stem cell transplantation for mixed-phenotype acute leukemia
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: December 07, 2025
Improvement in survival of patients with higher risk but not lower risk myelodysplastic syndromes over 20 years: A retrospective study from Nagasaki, Japan.
Journal: British journal of haematology
Published: September 30, 2025
Efficacy of Azacitidine Plus Venetoclax in Acute Myeloid Leukemia Transformed from Myelodysplastic Syndrome after Failure of Azacitidine Monotherapy.
Journal: Internal medicine (Tokyo, Japan)
Published: July 09, 2025
Allogeneic Hematopoietic Stem Cell Transplantation for Older Patients With Adult T-Cell Leukemia/Lymphoma: A Nationwide Retrospective Study.
Journal: Transplantation and cellular therapy
Published: June 28, 2025
Comprehensive analysis of serum immune complexes identifies chronic graft-versus-host disease-associated antigenic molecules: A study by the Nagasaki transplant group.
Journal: Human immunology
Published: May 17, 2025
Donor lymphocyte infusion-based therapy for relapsed adult T-cell leukemia/lymphoma after HLA-haploidentical hematopoietic stem cell transplantation.
Journal: Transplant immunology
Published: March 20, 2025
Prognostic Impact of Cytomegalovirus Reactivation After Transplantation From Cord Blood Compared to Other Donor Sources in Patients With Adult T-Cell Leukemia/Lymphoma in the Pre-Letermovir Era.
Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: March 05, 2025
RUNX1 expression is regulated by a super-enhancer and is a therapeutic target in adult T-cell leukemia/lymphoma.
Journal: Leukemia & lymphoma
Published: September 02, 2024
Improved survival among elderly patients with aggressive adult T-cell leukemia/lymphoma: Impact of mogamulizumab-containing chemotherapy.
Journal: International journal of hematology
Published: February 06, 2024
RAISING revealed a heterogenous pattern of HTLV-1 clonality after HLA-haploidentical peripheral blood stem cell transplantation for ATL.
Journal: Leukemia & lymphoma
Published: November 01, 2023
Last Updated: 09/26/2026